{"log_id": 6994699395092426998, "direction": 0, "words_result_num": 33, "words_result": [{"probability": {"variance": 0.003709, "average": 0.964759, "min": 0.797666}, "location": {"width": 233, "top": 154, "height": 27, "left": 249}, "words": "恩替卡韦可从大鼠乳汁分泌"}, {"probability": {"variance": 0, "average": 0.998646, "min": 0.998646}, "location": {"width": 25, "top": 154, "height": 25, "left": 1082}, "words": "局"}, {"probability": {"variance": 0.000738, "average": 0.96091, "min": 0.936668}, "location": {"width": 61, "top": 225, "height": 24, "left": 202}, "words": "致癌性"}, {"probability": {"variance": 0.007343, "average": 0.966384, "min": 0.553737}, "location": {"width": 725, "top": 252, "height": 37, "left": 247}, "words": "在小鼠和大鼠口服恩替卡韦的长期致癌性研究中,药物暴露量大约分别是人类最高推"}, {"probability": {"variance": 0.015656, "average": 0.955816, "min": 0.415137}, "location": {"width": 770, "top": 292, "height": 40, "left": 200}, "words": "荐剂(1.0mg/每天)的42倍(大鼠)和35倍(小鼠).在上述研究中,恩替卡韦致癌性"}, {"probability": {"variance": 2.8e-05, "average": 0.993987, "min": 0.988676}, "location": {"width": 55, "top": 297, "height": 30, "left": 1059}, "words": "国家"}, {"probability": {"variance": 0.001147, "average": 0.967736, "min": 0.917327}, "location": {"width": 120, "top": 344, "height": 24, "left": 201}, "words": "出现阳性结果"}, {"probability": {"variance": 0.010079, "average": 0.970455, "min": 0.409183}, "location": {"width": 725, "top": 370, "height": 41, "left": 244}, "words": "在小鼠试验中,当剂量至人体剂的3至40倍时,雄性或雌性小鼠的肺部腺瘤的发生"}, {"probability": {"variance": 0.003209, "average": 0.978055, "min": 0.648094}, "location": {"width": 762, "top": 409, "height": 42, "left": 198}, "words": "率增加、当剂量至人体剂量的40倍时,雄性或雌性小鼠的肺部肿瘤的发生率增加当剂"}, {"probability": {"variance": 0.007021, "average": 0.956045, "min": 0.62229}, "location": {"width": 766, "top": 449, "height": 41, "left": 199}, "words": "的人休剂量的3倍时,雄性小鼠的肺部腺瘤和肿瘤的发生率培加;当剂量至人体剂量的40"}, {"probability": {"variance": 0.009966, "average": 0.96091, "min": 0.534603}, "location": {"width": 770, "top": 488, "height": 41, "left": 195}, "words": "倍时,雌性小鼠的肺部腺瘤和肿瘤的发生率增加、小鼠先出现肺细胞增生,继而出现肺部肿"}, {"probability": {"variance": 0.002256, "average": 0.982302, "min": 0.72704}, "location": {"width": 773, "top": 527, "height": 41, "left": 193}, "words": "瘤,但给予本品的大鼠、狗和猴中并未发现肺细胞增生,这提示在小鼠体内发生的肺部肿瘤"}, {"probability": {"variance": 0.010967, "average": 0.964662, "min": 0.407948}, "location": {"width": 772, "top": 567, "height": 42, "left": 193}, "words": "可能具有种特异性。当剂量至人体剂量的42倍时,雄性小鼠的肝细胞肿瘤与混合瘤(肿"}, {"probability": {"variance": 0.007154, "average": 0.963157, "min": 0.570086}, "location": {"width": 772, "top": 606, "height": 42, "left": 192}, "words": "瘤和腺瘤)的发生半增加,当剂量至人体剂量的40倍时,雌性小鼠的血管性肿瘤(包括卵"}, {"probability": {"variance": 0.002016, "average": 0.976844, "min": 0.787901}, "location": {"width": 773, "top": 643, "height": 44, "left": 191}, "words": "巢,子宫的血管瘤和脾脏的血管肉瘤)发生率增加。在大鼠的试验中,当剂量至人体剂量的"}, {"probability": {"variance": 0.020068, "average": 0.941411, "min": 0.374512}, "location": {"width": 754, "top": 683, "height": 41, "left": 191}, "words": "24倍时,雌性大鼠的细胞腺瘤的发生率增加,混合瘤(肿瘤和腺)的发生率也增加"}, {"probability": {"variance": 0.007848, "average": 0.968249, "min": 0.510432}, "location": {"width": 773, "top": 720, "height": 43, "left": 191}, "words": "当剂量至人体剂量的35倍和24倍时,分别在雄性大鼠和雌性大鼠身上发现有脑胶质瘤。当"}, {"probability": {"variance": 0.002409, "average": 0.97371, "min": 0.77912}, "location": {"width": 526, "top": 765, "height": 38, "left": 188}, "words": "剂量至人体剂量的4倍时,在雌性大鼠身上发现有皮肤纤维瘤"}, {"probability": {"variance": 0.014296, "average": 0.955778, "min": 0.359122}, "location": {"width": 685, "top": 800, "height": 42, "left": 233}, "words": "日前尚不清楚本品啮齿类动物政性试验的结果能否预测本品对人体的致癌作用"}, {"probability": {"variance": 0.000992, "average": 0.982714, "min": 0.907478}, "location": {"width": 116, "top": 879, "height": 27, "left": 192}, "words": "[药代动力学]"}, {"probability": {"variance": 3e-06, "average": 0.998269, "min": 0.996575}, "location": {"width": 43, "top": 920, "height": 23, "left": 185}, "words": "吸收"}, {"probability": {"variance": 0.004877, "average": 0.972087, "min": 0.659856}, "location": {"width": 731, "top": 940, "height": 42, "left": 229}, "words": "健康人群口服用药后,本品被迅速吸收,0.5到1.5小时达到峰浓度(Cmax).每天给"}, {"probability": {"variance": 0.013958, "average": 0.951145, "min": 0.45121}, "location": {"width": 404, "top": 988, "height": 35, "left": 184}, "words": "药一次,6一10天后可达稳态,累积量约为两倍"}, {"probability": {"variance": 2.6e-05, "average": 0.996436, "min": 0.981836}, "location": {"width": 195, "top": 1059, "height": 28, "left": 183}, "words": "食物对口服吸收的影响"}, {"probability": {"variance": 0.01007, "average": 0.949527, "min": 0.533733}, "location": {"width": 734, "top": 1083, "height": 43, "left": 225}, "words": "进食标准高脂餐成低脂餐的同时口服0.5mg本品会导致药物吸收的轻微延迟(从原来"}, {"probability": {"variance": 0.021601, "average": 0.924234, "min": 0.47221}, "location": {"width": 760, "top": 1122, "height": 46, "left": 180}, "words": "的0.75小时变为1.0—1.5小时),Cmax降低44-46,药时曲线下面积(AUC)降低18"}, {"probability": {"variance": 0.005341, "average": 0.969866, "min": 0.670294}, "location": {"width": 462, "top": 1169, "height": 36, "left": 185}, "words": "0%。因此,本品应空腹服用(餐前或餐后至少2小时)"}, {"probability": {"variance": 5.7e-05, "average": 0.991291, "min": 0.983767}, "location": {"width": 44, "top": 1246, "height": 24, "left": 178}, "words": "分布"}, {"probability": {"variance": 0.012831, "average": 0.966225, "min": 0.354739}, "location": {"width": 732, "top": 1265, "height": 43, "left": 226}, "words": "药代动力学资料表明,其表观分布容积超过全身液体量,这说明本广泛分布于各组"}, {"probability": {"variance": 0, "average": 0.993007, "min": 0.993007}, "location": {"width": 23, "top": 1324, "height": 24, "left": 178}, "words": "织"}, {"probability": {"variance": 0.005313, "average": 0.962476, "min": 0.68828}, "location": {"width": 388, "top": 1347, "height": 36, "left": 223}, "words": "体外实验表明本品与人血浆蛋白结合率为13%"}, {"probability": {"variance": 0.011312, "average": 0.914489, "min": 0.71001}, "location": {"width": 100, "top": 1423, "height": 23, "left": 178}, "words": "代谢和清除"}, {"probability": {"variance": 0.033575, "average": 0.89547, "min": 0.413058}, "location": {"width": 728, "top": 1440, "height": 44, "left": 227}, "words": "在给人和大鼠服用C标记的思卡后:未观察到本晶的氧化或乙能化代谢物,但"}], "language": 3}